论文部分内容阅读
目的探讨缩宫素联合米索前列醇防治子宫收缩乏力性产后出血的临床疗效。方法 280例足月产妇,随机分为实验组与对照组,各140例。实验组予以缩宫素联合米索前列醇防治,对照组单纯给药缩宫素。比较两组临床疗效。结果实验组1例产后出血,发生率为0.71%;对照组有8例,发生率为5.71%,比较差异有统计学意义(P<0.05)。结论对于足月产妇,为了提升其子宫收缩乏力性产后出血的防治效果,选择缩宫素联合米索前列醇联合使用效果显著,是改善足月产妇宫缩质量以及缩短第三产程的重要保障。
Objective To investigate the clinical efficacy of oxytocin combined with misoprostol in preventing postpartum hemorrhage due to uterine atony. Methods Two hundred and eighty full-term pregnant women were randomly divided into experimental group and control group with 140 cases each. The experimental group was treated with oxytocin combined with misoprostol, while the control group was given oxytocin alone. The clinical efficacy of the two groups were compared. Results One case of postpartum hemorrhage in the experimental group was found to have a rate of 0.71%. There were 8 cases in the control group with a rate of 5.71%. The difference was statistically significant (P <0.05). Conclusion For full-term mothers, in order to enhance the prevention and treatment of postpartum hemorrhage due to uterine atony, the combination of oxytocin and misoprostol is effective. It is an important guarantee to improve the contractions and reduce the third stage of labor.